First Nebraska Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.97M | Buy |
105,768
+1,510
| +1% | +$40.2K | 0.27% | 70 |
|
|
2025
Q4 | $2.6M | Buy |
104,258
+528
| +0.5% | +$13.3K | 0.24% | 70 |
|
|
2025
Q3 | $2.64M | Sell |
103,730
-3,338
| -3% | -$82.4K | 0.24% | 72 |
|
|
2025
Q2 | $2.6M | Sell |
107,068
-1,931
| -2% | -$45K | 0.25% | 69 |
|
|
2025
Q1 | $2.76M | Buy |
108,999
+20,973
| +24% | +$549K | 0.27% | 67 |
|
|
2024
Q4 | $2.34M | Sell |
88,026
-53,089
| -38% | -$1.44M | 0.23% | 75 |
|
|
2024
Q3 | $4.08M | Buy |
141,115
+20,653
| +17% | +$602K | 0.4% | 56 |
|
|
2024
Q2 | $3.37M | Sell |
120,462
-1,174
| -1% | -$32.3K | 0.35% | 57 |
|
|
2024
Q1 | $3.38M | Sell |
121,636
-1,195
| -1% | -$33.2K | 0.35% | 61 |
|
|
2023
Q4 | $3.54M | Sell |
122,831
-30,945
| -20% | -$935K | 0.41% | 58 |
|
|
2023
Q3 | $5.1M | Buy |
153,776
+1,903
| +1% | +$67.3K | 0.63% | 41 |
|
|
2023
Q2 | $5.57M | Buy |
151,873
+8,894
| +6% | +$346K | 0.67% | 39 |
|
|
2023
Q1 | $5.83M | Buy |
142,979
+2,820
| +2% | +$122K | 0.74% | 32 |
|
|
2022
Q4 | $7.18M | Sell |
140,159
-607
| -0.4% | -$29.1K | 0.94% | 27 |
|
|
2022
Q3 | $6.16M | Buy |
140,766
+1,288
| +0.9% | +$62.6K | 0.88% | 29 |
|
|
2022
Q2 | $7.31M | Sell |
139,478
-513
| -0.4% | -$26.1K | 0.96% | 26 |
|
|
2022
Q1 | $7.25M | Sell |
139,991
-1,000
| -0.7% | -$51.9K | 0.86% | 29 |
|
|
2021
Q4 | $8.33M | Sell |
140,991
-1,289
| -0.9% | -$63.9K | 1% | 24 |
|
|
2021
Q3 | $6.12M | Buy |
142,280
+175
| +0.1% | +$7.75K | 0.8% | 31 |
|
|
2021
Q2 | $5.56M | Buy |
142,105
+10,176
| +8% | +$396K | 0.72% | 37 |
|
|
2021
Q1 | $4.78M | Buy |
131,929
+8,544
| +7% | +$303K | 0.64% | 37 |
|
|
2020
Q4 | $4.54M | Sell |
123,385
-233
| -0.2% | -$8.55K | 0.66% | 37 |
|
|
2020
Q3 | $4.3M | Buy |
123,618
+3,331
| +3% | +$117K | 0.74% | 34 |
|
|
2020
Q2 | $3.73M | Sell |
120,287
-983
| -0.8% | -$33.4K | 0.69% | 38 |
|
|
2020
Q1 | $3.76M | Buy |
121,270
+5,189
| +4% | +$177K | 0.83% | 33 |
|
|
2019
Q4 | $4.32M | Buy |
116,081
+4,075
| +4% | +$145K | 0.7% | 35 |
|
|
2019
Q3 | $3.82M | Buy |
112,006
+12,222
| +12% | +$444K | 0.63% | 35 |
|
|
2019
Q2 | $4.1M | Buy |
99,784
+6,527
| +7% | +$259K | 0.72% | 34 |
|
|
2019
Q1 | $3.76M | Sell |
93,257
-273
| -0.3% | -$10.9K | 0.68% | 36 |
|
|
2018
Q4 | $3.87M | Sell |
93,530
-424
| -0.5% | -$17.6K | 0.79% | 32 |
|
|
2018
Q3 | $3.93M | Sell |
93,954
-1,261
| -1% | -$48.5K | 0.67% | 34 |
|
|
2018
Q2 | $3.28M | Sell |
95,215
-1,166
| -1% | -$39.8K | 0.7% | 40 |
|
|
2018
Q1 | $3.25M | Buy |
96,381
+5,112
| +6% | +$176K | 0.65% | 41 |
|
|
2017
Q4 | $3.14M | Sell |
91,269
-19,148
| -17% | -$653K | 0.64% | 40 |
|
|
2017
Q3 | $3.74M | Sell |
110,417
-74
| -0.1% | -$2.38K | 0.82% | 33 |
|
|
2017
Q2 | $3.52M | Sell |
110,491
-1,222
| -1% | -$38.5K | 0.79% | 34 |
|
|
2017
Q1 | $3.63M | Buy |
111,713
+13,089
| +13% | +$413K | 0.81% | 34 |
|
|
2016
Q4 | $3.04M | Buy |
98,624
+18,342
| +23% | +$560K | 0.73% | 38 |
|
|
2016
Q3 | $2.58M | Buy |
80,282
+105
| +0.1% | +$3.51K | 0.67% | 40 |
|
|
2016
Q2 | $2.68M | Buy |
80,177
+1,471
| +2% | +$46.9K | 0.7% | 39 |
|
|
2016
Q1 | $2.21M | Sell |
78,706
-281
| -0.4% | -$8.03K | 0.61% | 40 |
|
|
2015
Q4 | $2.42M | Sell |
78,987
-2,029
| -3% | -$63.8K | 0.73% | 35 |
|
|
2015
Q3 | $2.41M | Hold |
81,016
| – | – | 0.77% | 35 |
|
|
2015
Q2 | $2.58M | Sell |
81,016
-2,300
| -3% | -$75K | 0.79% | 37 |
|
|
2015
Q1 | $2.75M | Sell |
83,316
-403
| -0.5% | -$12.8K | 0.81% | 36 |
|
|
2014
Q4 | $2.47M | Sell |
83,719
-3,653
| -4% | -$105K | 0.72% | 39 |
|
|
2014
Q3 | $2.45M | Sell |
87,372
-1,792
| -2% | -$50.3K | 0.7% | 39 |
|
|
2014
Q2 | $2.51M | Sell |
89,164
-896
| -1% | -$25.5K | 0.72% | 40 |
|
|
2014
Q1 | $2.74M | Buy |
90,060
+501
| +0.6% | +$14.9K | 0.85% | 35 |
|
|
2013
Q4 | $2.6M | Sell |
89,559
-1,634
| -2% | -$47.6K | 0.81% | 36 |
|
|
2013
Q3 | $2.49M | Buy |
+91,193
| New | +$2.48M | 0.86% | 36 |
|
Other funds holding PFE
VCM
VPM
First Nebraska Trust's PFE Position: Q1 2026 in Review
First Nebraska Trust increased its Pfizer (PFE) stake by 1.4% in Q1 2026, buying an estimated $40.2K and bringing the position to 105,768 shares worth $2.97M. The position accounts for 0.27% of the portfolio, ranked #70.
First Nebraska Trust first reported a position in PFE in Q3 2013 and has held it in 51 quarters since. The position peaked at $8.33M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- First Nebraska Trust held 105,768 shares of Pfizer worth $2.97M as of Q1 2026.
- First Nebraska Trust bought 1,510 Pfizer shares in Q1 2026, an estimated $40.2K.
- Pfizer made up 0.27% of First Nebraska Trust's portfolio in Q1 2026, its #70 holding.
- First Nebraska Trust first reported a position in Pfizer in Q3 2013 and has held it in 51 quarters since.
- First Nebraska Trust's Pfizer position peaked at $8.33M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on First Nebraska Trust's 13F filing for Q1 2026, filed 1 Jun 2026.